The global market for transdermal patches is experiencing rapid transformation, providing advanced solutions for the ...

The nonsteroidal anti-inflammatory drug (NSAID) flunixin meglumine has been approved by the FDA for fever associated with ...

近日，浙江大学药学院、金华研究院和先进药物递释系统全国重点实验室张宇琪研究员、顾臻教授团队报道了一种用于按需透皮给药的可穿戴透皮系统，该系统由装有电响应水凝胶的可穿戴设备和聚合物微针贴片组成，它不仅能通过离子电渗提高带电活性成分的透皮深度，还能通过程 ...

Vitamin patches offer an intriguing alternative to traditional supplements but their effectiveness remains uncertain Read ...

Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System ...

Delhi, March 17, 2025 (GLOBE NEWSWIRE) -- Global Transdermal Patch Market Opportunity, Patch Dosage, Price & Clinical Trials Insight 2030 Report Highlights & Findings: The global market for ...

Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).

SUMMIT, N.J., March 17, 2025 /PRNewswire/ -- In a new study published in the journal GeroScience, VAS101 (Vasceptor®), a novel curcumin transdermal formulation developed by Vascarta Inc.

PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support ...

A 60-patient, randomized, double-blind, placebo-controlled phase I clinical study of VAS101 (topical curcumin gel) in ...